Kobayashi Y,Zhai YL,Linuma M,et al.Effects of a GnRH analogue on human smooth muscle cells cultured from normal myometrial and from uterine leiomyomal tissues[J].Mol Hum Reprod,1997,3:91-93.
[2]
Chia CC,Huang SC,Chen SS,et al.Ultrasonographic evaluation of the change in uterine fibroids induced by treatment with a GnRH analog[J].Taiwan J Obstet Gynecol,2006,45(2):124-128.
[3]
Imai A,Sugiyama M,Furui T,et al.Treatment of perimenopausal Women with uterine myoma:successful use of a adepot GnRH agonist leading to a natural menopause[J].J Obstet Gynecol,2003,23(5):518-520.
[4]
Scialli AR,Jestila KJ.Sustained benefits of leuprolide acetate with or without subsequent medroxypro-gesterone acetate in the nonsurgical Management of leiomyomata uteri[J].Fertil Steril,1995,64:313-320.
[5]
Filicori M.A conservative approach to the managenment of uterine leiomyoma:pituitary desensitization by a luteinizing hormone releasing hormone analogue[J].Am J Obstet Gynecol,1983,147(6):726.
Makita K,Ishitani K,Ohta H,et al.Long term effects on bone mineral density and bone metabolism of 6months’treatment with gonadotropin-releasing hormone analogues in Japanese women:comparison of buserelin acetate with leuprolide acetate[J].J Bone Miner Metab,2005,23(5):389-394.
[11]
Stovall TG,Ling FW,Henry LC,et al.A randomized trial evaluating Leuprolide acetate before hysterectomy as a treatment for leiomyomad[J].Am J Obstet Gynecol,1991,164:1 420-1 426.
